{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:49:44Z","timestamp":1769640584077,"version":"3.49.0"},"reference-count":17,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1006,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Australasian Journal of Dermatology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1111\/ajd.12002","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T13:16:21Z","timestamp":1354194981000},"page":"e1-e3","source":"Crossref","is-referenced-by-count":10,"title":["Exacerbation of lymphomatoid papulosis during rituximab therapy"],"prefix":"10.1111","volume":"55","author":[{"given":"Olivia","family":"McCurdy","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology; Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"McCormack","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology; Melbourne Australia"},{"name":"Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ritchie","sequence":"additional","affiliation":[{"name":"Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia"},{"name":"Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Miles","family":"Prince","sequence":"additional","affiliation":[{"name":"Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia"},{"name":"Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,11,29]]},"reference":[{"key":"10.1111\/ajd.12002-BIB0001|ajd12002-cit-0001","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"key":"10.1111\/ajd.12002-BIB0002|ajd12002-cit-0002","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1111\/ajd.12002-BIB0003|ajd12002-cit-0003","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.0303-6987.2006.00507.x","article-title":"Pathobiology of CD30+ cutaneous T-cell lymphomas","volume":"33","author":"Kadin","year":"2006","journal-title":"J. Cutan. Pathol."},{"key":"10.1111\/ajd.12002-BIB0004|ajd12002-cit-0004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12016-007-8021-6","article-title":"Rituximab in treatment resistant auto-immune blistering skin disorders","volume":"34","author":"Schmidt","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1111\/ajd.12002-BIB0005|ajd12002-cit-0005","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"key":"10.1111\/ajd.12002-BIB0006|ajd12002-cit-0006","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.24998","article-title":"Depletion of functionally active CD20+ T-cells by rituximab treatment","volume":"60","author":"Wilk","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1111\/ajd.12002-BIB0007|ajd12002-cit-0007","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2008.12.010","article-title":"Lymphomatoid papulosis while on efalizumab. Letter to the Editor","volume":"61","author":"Leo","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12002-BIB0008|ajd12002-cit-0008","doi-asserted-by":"crossref","first-page":"R666","DOI":"10.1186\/ar1724","article-title":"Dermatologic conditions during TNF-alpha blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1111\/ajd.12002-BIB0009|ajd12002-cit-0009","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ibd.20762","article-title":"Lymphomatoid papulosis in a patient with Crohn's disease treated with infliximab","volume":"15","author":"Outlaw","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1111\/ajd.12002-BIB0010|ajd12002-cit-0010","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1365-2133.2005.06548.x","article-title":"Lymphomatoid papulosis in a patient with atopic eczema on long term cyclosporine therapy","volume":"152","author":"Laube","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/ajd.12002-BIB0011|ajd12002-cit-0011","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-4362.1997.tb04181.x","article-title":"Lymphomatoid papulosis and FK506","volume":"36","author":"Siddiqui","year":"1997","journal-title":"Int. J. Dermatol."},{"key":"10.1111\/ajd.12002-BIB0012|ajd12002-cit-0012","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0190-9622(91)70220-V","article-title":"PUVA-induced lymphomatoid papulosis in a patient with mycosis fungoides","volume":"25","author":"Wolf","year":"1991","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12002-BIB0013|ajd12002-cit-0013","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0015-0282(16)48991-0","article-title":"Exacerbation of lymphomatoid papulosis during treatment with danazol","volume":"44","author":"Wise","year":"1985","journal-title":"Fertil. Steril."},{"key":"10.1111\/ajd.12002-BIB0014|ajd12002-cit-0014","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/archderm.1993.01680220098022","article-title":"Lymphomatoid papulosis followed by Hodgkin's lymphoma differential response to therapy","volume":"129","author":"Zackheim","year":"1993","journal-title":"Arch. Dermatol."},{"key":"10.1111\/ajd.12002-BIB0015|ajd12002-cit-0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B-cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1111\/ajd.12002-BIB0016|ajd12002-cit-0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.175.1.21","article-title":"Cutting edge: the link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance","volume":"175","author":"Knoechel","year":"2005","journal-title":"J. Immunol."},{"key":"10.1111\/ajd.12002-BIB0017|ajd12002-cit-0017","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00262-011-1168-2","article-title":"Rituximab-induced direct inhibition of T-cell activation","volume":"61","author":"Stroopinsky","year":"2012","journal-title":"Cencer Immunol. Immunother."}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajd.12002","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajd.12002\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T04:54:28Z","timestamp":1714625668000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.12002"}},"subtitle":["LyP exacerbated by rituximab"],"short-title":[],"issued":{"date-parts":[[2012,11,29]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1111\/ajd.12002","relation":{},"ISSN":["0004-8380"],"issn-type":[{"value":"0004-8380","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11,29]]}}}